Related Experiment Video
Updated: Jun 22, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Microscale sample preparation for PCR of C. difficile infected stool.
Sara Gillers1, Christopher D Atkinson, Aaron C Bartoo
1Department of Medicine, Section of Gastroenterology, Boston University School of Medicine, Suite 504, 650 Albany Street, Boston, MA 02118, United States.
This study presents a microfluidic chip for preparing stool samples to detect Clostridium difficile. The validated assay accurately identifies the bacteria, offering potential global health benefits.
Area of Science:
- Microfluidics
- Molecular Diagnostics
- Clinical Microbiology
Background:
- Clostridium difficile infection (CDI) is a significant healthcare challenge.
- Accurate and rapid diagnostics are crucial for effective CDI management.
- Current diagnostic methods may require complex sample preparation.
Purpose of the Study:
- To design and validate a microfluidic sample preparation chip for human stool samples.
- To develop a polymerase chain reaction (PCR) assay for detecting Clostridium difficile.
- To integrate sample preparation and detection for improved diagnostic efficiency.
Main Methods:
- Development of a novel microfluidic chip for automated stool sample processing.
- Establishment of a sensitive PCR assay capable of differentiating C. difficile from intestinal flora.
- On-chip nucleic acid extraction protocol with a limit of detection of 5.0x10(-3) ng of template DNA.
- Validation of the integrated system using clinical samples (positive and negative).
Main Results:
- The microfluidic chip successfully processed human stool samples.
- The developed PCR assay demonstrated high specificity for C. difficile.
- The on-chip nucleic acid extraction achieved sensitive DNA detection.
- The validated assay and chip showed reliable performance with clinical specimens.
Conclusions:
- The designed microfluidic chip enables efficient sample preparation for C. difficile detection.
- The integrated assay provides a sensitive and specific method for diagnosing CDI.
- This technology has potential applications in both developed and developing healthcare settings.
More Related Videos
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
08:14A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
Published on: February 28, 2018